Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
Form 144 reports a planned sale of 73,250 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 1,923,120.15, to be sold on or about 02/09/2026 on the NASDAQ exchange.
The shares were acquired as restricted stock and performance shares on 08/28/2020 and 09/22/2022. The filing also lists multiple sales of common shares over the prior three months by Oleg Khaykin and related irrevocable trusts, with individual transactions ranging up to 74,315 shares and gross proceeds exceeding 1,700,000.00 in a single sale.
Viavi Solutions Inc. President & CEO Oleg Khaykin reported a sale of common stock. On February 9, 2026, he sold 73,250 shares of Viavi common stock at a weighted average price of $26.25 per share, executed in multiple trades between $26.25 and $26.26.
After this transaction, Khaykin beneficially owned 1,635,621 shares of common stock directly. In addition, 40,238 shares were held indirectly as common stock by his spouse, which are reported as indirect beneficial ownership.
Viavi Solutions Inc. President and CEO Oleg Khaykin reported open‑market sales of company common stock. On February 6, 2026, he sold 29,887 shares at $26.30 per share and 40,679 shares at $26.25 per share, with the latter price disclosed as a weighted average for trades between $26.24 and $26.30.
Following these transactions, Khaykin beneficially owned 1,708,871 shares of Viavi common stock directly. In addition, 40,238 shares were reported as indirectly owned, held by the reporting person’s spouse.
VIAV shareholder Oleg Khaykin has filed a Form 144 to sell 40,679 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ around February 6, 2026, with an aggregate market value of $1,067,693.58 and 231,389,345 shares outstanding.
The shares to be sold were acquired as restricted stock from the issuer on August 28, 2019 in two grants of 34,345 and 6,334 shares. Over the past three months, Khaykin and related irrevocable trusts have sold multiple common stock blocks, including 70,000 shares on February 5, 2026 for $1,715,000 and 40,238 shares on December 5, 2025 for $704,165.
A shareholder filed a notice under Rule 144 to sell up to 29,887 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $786,028.10. The filing notes 23,138,945 shares outstanding.
The 29,887 shares come from restricted stock acquired from the issuer on 08/28/2022. The form also lists prior sales over the past three months by Oleg Khaykin and related irrevocable trusts, including 70,000 shares sold on 02/05/2026 for $1,715,000.00.
VIAV Form 144 shows planned insider resale of common stock. A total of 103,862 common shares are indicated for sale through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,704,826.13, against 231,389,345 common shares outstanding, to be sold on or about February 5, 2026 on NASDAQ.
The seller account is identified as THE JABBAR FAMILY TRUST. The securities come from restricted stock that vested under a registered plan across multiple dates from 2010 to 2024. Over the prior three months, the trust sold 30,000 common shares on November 26, 2025 for gross proceeds of $539,073.00 and 50,000 common shares on February 3, 2026 for $1,293,190.00.
A person associated with symbol VIAV has filed a notice of proposed sale under Rule 144 for 70,000 shares of common stock, with an aggregate market value of 1,715,000.00. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an approximate sale date of 02/05/2026. The issuer had 231,389,345 shares of common stock outstanding.
The filing also lists earlier sales over the prior three months by Oleg Khaykin and related irrevocable trusts, including individual transactions such as 74,315 shares sold on 02/04/2026 and multiple sales in early 12/2025 with gross proceeds in the hundreds of thousands of dollars each.
An affiliate of the issuer, identified as Gary Staley, has filed a Form 144 notice to sell 24,237 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $579,991.41. The issuer’s common stock is listed on the NASDAQ, with 231,389,345 shares outstanding. The approximate sale date indicated is February 5, 2026. Staley also reported three prior sales of common shares over the past three months, each generating gross proceeds between roughly $537,632 and $588,406.
VIAVI SOLUTIONS INC. executive Gary W. Staley, SVP Global Sales NSE, reported selling a total of 24,237 shares of Common Stock in two open-market sales on February 5, 2026, at $23.93 per share. After these transactions, he directly holds 136,267 shares of Common Stock.
Viavi Solutions President and CEO Oleg Khaykin reported selling 70,000 shares of the company’s common stock at $24.50 per share. After this sale, he directly holds 1,779,437 common shares. In addition, 40,238 common shares are held indirectly through his spouse.